Characteristics of Patients With Opioid Use Disorder Associated With Performing Overdose Reversals in the Community: An Opioid Treatment Program Analysis

被引:16
作者
Katzman, Joanna G. [1 ,2 ,3 ]
Greenberg, Nina H. [4 ]
Takeda, Mikiko Y. [5 ]
Balasch, Monica Moya [1 ]
机构
[1] Univ New Mexico, Dept Neurosurg, Sch Med, MSC 10-5615, Albuquerque, NM 87131 USA
[2] Univ New Mexico, Dept Psychiat, Albuquerque, NM 87131 USA
[3] Univ New Mexico, Coll Nursing, MSC 10-5615, Albuquerque, NM 87131 USA
[4] Univ New Mexico, Dept Math & Stat, Albuquerque, NM 87131 USA
[5] Univ New Mexico, Dept Pharm Practice & Adm Serv, Coll Pharm, Albuquerque, NM 87131 USA
关键词
characteristics; harm reduction; naloxone; opioid; overdose; INJECTION-DRUG USERS; HEROIN OVERDOSE; NALOXONE;
D O I
10.1097/ADM.0000000000000461
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Objective: The primary outcome of this study is to identify characteristics of study participants in a large opioid treatment program (OTP) for opioid use disorder (OUD) who used take-home naloxone to perform 1 or more opioid overdose (OD) reversal(s) in the community. Methods: This 6-month prospective cohort study provided take-home naloxone and opioid OD education for 287 study participants with OUD. Characteristics associated with use of the take-home naloxone were determined from among 16 variables using multivariable logistic regression. Results: The study participants who had greater odds of using the take-home naloxone to perform OD reversals, compared to those who did not use the take-home naloxone, (a) received emergency room care themselves for OD (OR = 4.89, 95% CI 1.54-15.52, P = 0.007), (b) previously witnessed someone else OD (OR = 5.67, 95% CI 1.24-25.87, P = 0.025), (c) tested positive for 2 or more illicit substances at their 6-month urine analysis (OR = 5.26, 95% CI 1.58-17.54, P = 0.007) or were missing their 6-month urine analysis (OR = 3.46, 95% CI 1.42-8.43, P = 0.006). In addition, they had greater odds of being (d) less than 30 years old (OR = 2.80, 95% CI 1.02-7.66, P = 0.045), and (e) Hispanic (OR = 3.98, 95% CI 1.41-11.21, P = 0.009). Conclusions: This study prospectively identified several characteristics of patients enrolled in an OTP with increased odds of using take-home naloxone in their social networks. Future harm reduction efforts may benefit by using targeted characteristics to identify those most likely to use naloxone in their communities.
引用
收藏
页码:131 / 138
页数:8
相关论文
共 50 条
  • [31] Community Support for Harm Reduction and Treatment of Opioid Use Disorder
    Hanson, Bridget L.
    Finley, Kari
    Otto, Jay
    Ward, Nicholas J.
    Banik, Swagata
    JOURNAL OF COMMUNITY HEALTH, 2024, 49 (04) : 724 - 731
  • [32] The Mobile Overdose Response Program: A mobile, low-threshold opioid use disorder treatment model in Philadelphia
    Lowenstein, Margaret
    Popova, Ellena
    Jalloh, Aminata
    Mazzella, Silvana
    Botcheos, Denise
    Bertocchi, Jennifer
    Westfahl, Shawn
    Garcia, Kristine Pamela
    Truchil, Rachael
    Chertok, Judy
    JOURNAL OF SUBSTANCE USE & ADDICTION TREATMENT, 2024, 164
  • [33] Respecting autonomy and capacity in patients with opioid use disorder
    Mullins, Michael E.
    Kroll, Melissa R.
    Liss, David B.
    JOURNAL OF EMERGENCY MEDICINE, 2025, 68 : 111 - 112
  • [34] Risks of returning to opioid use at treatment entry and early in opioid use disorder treatment: Role of non-opioid substances
    Castillo, Felipe
    Hu, Mei-Chen
    Liu, Ying
    Balise, Raymond R.
    Weiss, Roger D.
    Rotrosen, John
    Nunes, Edward, V
    Saxon, Andrew J.
    Feaster, Daniel J.
    Luo, Sean X.
    DRUG AND ALCOHOL DEPENDENCE, 2023, 251
  • [35] Predictors of enrollment in opioid agonist therapy after opioid overdose or diagnosis with opioid use disorder: A cohort study
    Macmadu, Alexandria
    Paull, Kimberly
    Youssef, Rouba
    Batthala, Sivakumar
    Wilson, Kevin H.
    Samuels, Elizabeth A.
    Yedinak, Jesse L.
    Marshall, Brandon D. L.
    DRUG AND ALCOHOL DEPENDENCE, 2021, 226
  • [36] Predictors of enrollment in opioid agonist therapy after opioid overdose or diagnosis with opioid use disorder: A cohort study
    Macmadu, Alexandria
    Paull, Kimberly
    Youssef, Rouba
    Batthala, Sivakumar
    Wilson, Kevin H.
    Samuels, Elizabeth A.
    Yedinak, Jesse L.
    Marshall, Brandon D. L.
    DRUG AND ALCOHOL DEPENDENCE, 2021, 219
  • [37] Engineering Approaches for Addressing Opioid Use Disorder in the Community
    Griffin, Paul M.
    ANNUAL REVIEW OF BIOMEDICAL ENGINEERING, VOL 22, 2020, 22 (22): : 207 - 229
  • [38] Neighborhood-Level and Spatial Characteristics Associated with Lay Naloxone Reversal Events and Opioid Overdose Deaths
    Rowe, Christopher
    Santos, Glenn-Milo
    Vittinghoff, Eric
    Wheeler, Eliza
    Davidson, Peter
    Coffin, Philip O.
    JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE, 2016, 93 (01): : 117 - 130
  • [39] Opioid Use Disorder: Medical Treatment Options
    Coffa, Diana
    Snyder, Hannah
    AMERICAN FAMILY PHYSICIAN, 2019, 100 (07) : 416 - 425
  • [40] Inpatient Opioid Use Disorder Treatment by Generalists is Associated With Linkage to Opioid Treatment Programs After Discharge
    Tierney, Hannah R.
    Rowe, Christopher L.
    Coffa, Diana A.
    Sarnaik, Shashi
    Coffin, Phillip O.
    Snyder, Hannah R.
    JOURNAL OF ADDICTION MEDICINE, 2022, 16 (02) : 169 - 176